Baker's Cyst (Popliteal Cyst)

The VerdictMODERATE CONVICTION

The cyst is a symptom of an irritated knee joint, not a primary problem.

Stand up and feel the back of your knee. Then bend your knee 30 to 40 degrees. If the lump feels firm when straight and softens when bent, that is Foucher's sign — typical for a Baker's cyst. Get an ultrasound to confirm. That is the right first scan, not an MRI.

What this actually is: a fluid-filled bulge of the gastrocnemio-semimembranosus bursa behind the knee, almost always downstream of intra-articular pathology (most commonly knee osteoarthritis with synovitis or effusion, secondarily a degenerative meniscal tear, less commonly inflammatory arthropathy).
What most people get wrong: repeat aspiration as the treatment plan. The valve continues to pump synovial fluid posteriorly as long as the joint is irritated. Aspiration without joint-directed care reliably recurs.
Start here: confirm the diagnosis with ultrasound, screen for red flags, then treat the upstream joint pathway (knee OA exercise therapy 8-12 weeks minimum, or meniscal-tear conservative pathway, or rheumatology referral). Asymptomatic incidentally-detected cysts get observation only.

Your knee joint is connected to a small sac at the back of the knee through a one-way valve. When the joint is irritated, usually by arthritis or a meniscal issue, it makes extra fluid, and the valve pumps that fluid backward into the sac. The sac is the visible swelling. Aspirating the sac is like emptying a bucket while the tap is still running. Turn the tap off — calm the joint — and the bucket settles on its own.

What Works

A four-arm decision tree by symptom severity and upstream driver. The single most important rule is the one repeated below: treat the joint, not just the cyst.

Treatment hierarchy for Baker's cyst — upstream-pathology-first approach

Tier 1 — Strong Evidence

1. Treat the upstream intra-articular pathology HIGH

For KOA: supervised graded exercise therapy 8-12 wk minimum, weight loss when applicable, NSAID short course for flares (cross-protocol KOA-exercise-as-medicine 2026-03-18). For meniscal tear: conservative pathway. For inflammatory arthropathy: disease-modifying care via rheumatology.

Mechanism is unambiguous: the cyst fills under intra-articular pressure. Settle the joint, the cyst settles. Picerno 2021 PMID 34348320 (N=130 prospective comparison) showed cyst presence increased baseline KOOS symptom burden but conservative therapy improved KOOS at 3 months regardless. Tsifountoudis 2020 PMID 31888367 confirms persistence is driven by the underlying joint disease, not the cyst itself. Saylik 2020 PMID 32149934 SR converges on the same rule.

2. Ultrasound first-line for diagnosis and monitoring HIGH

Posterior knee, longitudinal + transverse views; patient prone, knee extended; image the gap between medial gastrocnemius and semimembranosus tendon. Repeat at 4-12 week intervals if monitoring response.

Hayashi 2022 PMID 36510299 first MA of 13 studies (N=1,011, mean age 32.2 y) reports high pooled sensitivity, high specificity, AUC near unity vs MRI/pathology reference. Naredo 2003 PMID 12734890 confirmed US is superior to clinical exam in RA cohorts. Anchal 2024 PMID 40457908 N=114 confirmed US picks up cysts that clinical exam misses in primary KOA. MRI is second-line — used when intra-articular workup will change management or atypical features raise differential concern.

Tier 2 — Moderate Evidence

3. Single intra-articular corticosteroid for breakthrough symptoms in KOA + cyst MODERATE

Single ultrasound-guided injection into the knee joint: triamcinolone acetonide 40 mg or methylprednisolone 40-80 mg. NOT a routine combination with exercise — this is for breakthrough relief.

Acebes 2006 PMID 16547992 prospective uncontrolled N=30 of KOA + symptomatic Baker's cyst given a single triamcinolone 40 mg injection: significant reduction in cyst area, wall thickness, pain, swelling, and gain in ROM at 4 weeks. Cyst-area reduction correlated with ROM gain. Important null: Henriksen 2016 PMID 26746147 RCT sub-study N=100 found NO specific Baker's-cyst US benefit from adding IA steroid to a 12-week supervised exercise program (synovial-thickness group difference 2.2 mm, 95% CI -0.5 to 4.8, p=0.11). Position the injection as a breakthrough-symptom tool, not a routine adjunct.

4. Arthroscopic decompression of the cyst valve combined with treatment of the joint pathology MODERATE-HIGH

When ≥3-6 months of conservative care has failed AND symptoms are disabling AND a treatable intra-articular driver is confirmed AND the cyst is large or producing mechanical symptoms. One-stage operation. Cyst wall preservation = cyst wall resection on functional outcomes; surgeon-patient decision.

Han 2024 PMID 38700675 MA k=4 N=214 and Zhang 2021 PMID 33620529 MA both report equivalent functional outcomes (Lysholm, Rauschning-Lindgren grade) for preservation vs resection. Cao 2025 PMID 40514696 RCT N=60 confirms equivalent VAS, Lysholm, and R-L grade at 12 months. Resection wins on imaging-resolution rate (74.1% vs 46.4% complete cyst resolution on MRI, p=0.032) at the cost of longer operative time and higher ecchymosis rate (20% vs 6.7%). Saylik 2020 PMID 32149934 and Sansone 2016 PMID 26879283 confirm modern arthroscopic + intra-articular treatment outperforms historical isolated open excision on recurrence.

5. Ultrasound-guided cyst aspiration ± IA corticosteroid as a bridge MODERATE

For mechanical symptoms from large cysts (>5 cm, posterior fullness limiting flexion) while the upstream joint pathway is being addressed. Never as a standalone cure.

Symptomatic relief within days. Recurrence is high if used alone — the valve refills the bursa as long as the joint is irritated. Saylik 2020 PMID 32149934 SR makes the recurrence pattern explicit. Frame to the patient: the aspiration buys time, the joint pathway buys the result.

Tier 3 — Selected / Emerging

6. Sclerotherapy / radiosynoviorthesis EMERGING

For highly selected refractory cases where surgery is not feasible. Pichler 2020 PMID 32869226 retrospective influence-of-radiosynoviorthesis on cyst volume; small selected cohorts. Limited evidence; not first-line.

What Doesn't Work

"Drain the cyst" as a stand-alone plan. The valve refills the bursa as long as the joint is irritated. Repeated isolated aspiration recurs reliably.
Routine aspiration of asymptomatic, incidentally detected cysts. No indication, recurrence near-universal, false reassurance risk. Observation is the correct action.
Routine surgical excision of asymptomatic cysts. Not indicated.
Routine combination of IA steroid with a 12-week exercise program as a Baker's-cyst-specific adjunct. Henriksen 2016 PMID 26746147 RCT sub-study found no specific US-detected cyst benefit beyond exercise alone. IA steroid is for breakthrough relief, not a routine adjunct.
Counselling TKA candidates that the operation will eliminate the cyst. Tsifountoudis 2020 PMID 31888367 prospective N=105 with 86.7% mid-term follow-up: cyst persists in 85.3% at 1 year and 33.0% at 4.9 years; 56.7% of mid-term persisting cysts still symptomatic. Set expectations explicitly.
Open cyst excision as first-line where arthroscopy is feasible. Higher historical recurrence and longer recovery without functional advantage (Saylik 2020 PMID 32149934; Sansone 2016 PMID 26879283).
"The cyst wall must be completely resected to prevent recurrence." Han 2024 MA, Zhang 2021 MA, and Cao 2025 RCT all show preservation gives equivalent function with fewer complications.

Exercise Prescription

For KOA-secondary cysts. Examples — your physical therapist will choose the right ones. The pain rule applies to every exercise.

Exercise	Sets × Reps	Frequency
Quad sets (5-sec hold)	3 × 10	Daily
Straight-leg raise	3 × 10	Daily
Mini-squat to comfortable depth (chair-supported)	2-3 × 8-10	4-5x/wk
Standing hamstring curl	3 × 10 each side	4x/wk
Heel raises	3 × 12	4x/wk
Hip abductor work (clamshells / side-lying lifts)	2-3 × 10 each side	4x/wk
Stationary cycling (moderate resistance, comfortable cadence)	10-20 min	3-5x/wk

Pain rule: ≤2/10 during exercise AND ≤2/10 24-h flare. Stop with sharp pain, locking, sudden calf swelling, or new neurological symptoms. Inherited from cross-protocol consistency with proprioception-training, exercise-prescription-chronic-pain, and eccentric-loading.

Return to Training

Pain ≤2/10 during exercise AND ≤2/10 24-h flare for 2 consecutive weeks
Full active knee flexion and extension without sharp pain
Single-leg sit-to-stand symmetric with the unaffected side, no compensation
30+ minutes of walking without symptom flare beyond the pain rule
KOOS Pain and ADL sub-scales improved from baseline
Resolution or stabilisation of any concurrent effusion on examination
No new red flags (no recurrent calf swelling, no new neurological signs, no pulsatile mass)
Patient understands the upstream-pathology rule and the long-term plan for the underlying joint condition

Note: the cyst itself may take longer to shrink than the symptoms do, and may not fully resolve. That is normal and not a treatment failure as long as KOOS and function are improving.

Red Flags — When to Refer Immediately

Acute calf pain + swelling + warmth + bruising tracking down the calf: rule out DVT same-day. Cyst rupture mimics deep vein thrombosis (pseudo-thrombophlebitis). Wells score, D-dimer, compression duplex ultrasound.
New foot drop, paraesthesia in the lateral leg or dorsum of the foot: common peroneal nerve compression by the cyst (Yan 2018 PMID 29668644).
Pulsatile or expansile mass, vascular bruit, claudication-type symptoms: popliteal artery aneurysm, popliteal vein aneurysm with PE risk (Lin 2021 PMID 34297976), cystic adventitial disease (Hardin 2016 PMID 26933185; Buisseret 1997 PMID 9357478).
Solid or heterogeneous mass on ultrasound, rapid growth, constitutional symptoms (weight loss, night sweats): soft-tissue tumour (synovial / myxoid sarcoma).
Fever + warm swollen joint + raised inflammatory markers: septic arthritis with associated cyst (Silveira 1993 PMID 8484130). Do NOT aspirate the cyst before joint evaluation.
Inflammatory pattern (morning stiffness >30 min, symmetrical small-joint involvement, raised ESR/CRP): underlying rheumatoid arthritis or seronegative spondyloarthropathy.

Refer to: A&E or same-day ambulatory DVT clinic for acute calf-symptom presentations; orthopedics urgently for foot drop or rapid-growth mass; vascular surgery for pulsatile mass or PE risk; A&E for fever + warm joint; rheumatology for inflammatory pattern.

Conviction

Moderate Overall

Per-endpoint stratified: HIGH for ultrasound first-line diagnosis (Hayashi 2022 MA) and the upstream-pathology rule (converging mechanism + clinical signal across Saylik 2020, Picerno 2021, Tsifountoudis 2020, plus the wider KOA-exercise-as-medicine evidence base). MODERATE-HIGH for arthroscopic decompression preservation = resection on function (Han 2024 MA, Zhang 2021 MA, Cao 2025 RCT) and for the TKA-does-not-eliminate-cyst short-term observation (Tsifountoudis 2020 N=105). MODERATE for single IA corticosteroid for symptomatic KOA + cyst and for ultrasound-guided aspiration as a bridge. LOW for open excision as first-line (effectively superseded) and for sclerotherapy / radiosynoviorthesis as first-line. DEBUNKED-LOW for routine aspiration of asymptomatic cysts.

What would change my mind on routine IA steroid + exercise

A multi-centre RCT of 200+ adults with symptomatic KOA-associated Baker's cyst comparing 12 weeks of supervised graded exercise alone vs exercise + single ultrasound-guided IA corticosteroid vs exercise + cyst aspiration + IA corticosteroid, with primary endpoints of KOOS-pain at 6 months, ultrasound cyst area at 6 months, and recurrence at 12 months. If the steroid arm beat exercise alone on KOOS-pain by ≥10 points, single IA steroid + exercise would upgrade from MODERATE direction-only to HIGH. If it failed (replicating Henriksen 2016 in a cyst-stratified primary-endpoint design), routine combination would downgrade to LOW.

What would change my mind on the asymptomatic-cyst observation rule

A prospective natural-history cohort of 500+ adults with incidentally-detected asymptomatic Baker's cyst on ultrasound, followed for 5 years with sequential US, KOOS, and symptomatic-conversion rate. This would close the largest practical clinical gap: how often does an asymptomatic cyst become symptomatic, and what predicts it. A high spontaneous-conversion rate (e.g. >30% at 5 years with predictable predictors) might justify earlier upstream-pathway intervention even in the asymptomatic cohort.

Go Deeper

Don't want to guess what works next time you're injured? Join The Verdict for free weekly, evidence-graded protocols.

Get The Verdict — Free

Sources

Hayashi N et al. (2022). Diagnostic accuracy MA of ultrasound for Baker's cyst, k=13 studies, N=1,011. J Ultrasound. PMID 36510299.
Saylik M (2020). SR popliteal cysts nonoperative + operative, k=30 studies 1970-2019. Knee. PMID 32149934.
Han et al. (2024). MA cyst wall preservation vs resection in arthroscopic decompression, k=4 studies, 214 knees. J Orthop Surg Res. PMID 38700675.
Zhang et al. (2021). MA cyst wall preservation vs resection. J Orthop Surg Res. PMID 33620529.
Cao et al. (2025). Prospective RCT N=60 of arthroscopic internal drainage vs internal drainage + cyst wall resection, 12-month follow-up. J Orthop Surg Res. PMID 40514696.
Acebes JC et al. (2006). Prospective uncontrolled N=30 of single IA triamcinolone 40 mg in KOA + Baker's cyst, 4-week assessment. J Ultrasound Med. PMID 16547992.
Henriksen M et al. (2016). RCT sub-study N=100 of IA steroid + 12-week exercise vs placebo + exercise in KOA. Arthritis Res Ther. PMID 26746147.
Picerno V et al. (2021). Prospective comparative N=130 of KOA ± Baker's cyst, 3-month conservative outcomes. Reumatismo. PMID 34348320.
Tsifountoudis I et al. (2020). Prospective N=105 of Baker's cyst persistence post-TKA at 1.0 y and 4.9 y. Knee Surg Sports Traumatol Arthrosc. PMID 31888367.
Sansone V & de Ponti A (2016). SR/MA of surgical treatment of popliteal cyst. Int Orthop. PMID 26879283.
Naredo E et al. (2003). RA cohort — ultrasound superior to clinical exam for cyst detection. J Rheumatol. PMID 12734890.
Anchal N et al. (2024). Observational N=114 of MSK ultrasonography for Baker's cyst incidence in primary KOA. Mymensingh Med J. PMID 40457908.
Zhao et al. (2023). Risk-factor analysis N=54 — residual cyst after arthroscopic decompression and cystectomy is associated with high-grade chondral lesions (Outerbridge III-IV). Medicine (Baltimore). PMID 36921759.
Saylik M & Tan T (2017). Prospective comparative N=76 of arthroscopic vs open approaches. PMID 29070055.
Wei W et al. (2022). SR of knee inflammation markers (effusion, synovitis, Baker's cysts, cytokines, CRP) and pain in KOA. PMID 34968719.
Pichler G et al. (2020). Retrospective influence of radiosynoviorthesis on Baker's cyst volume. Nuklearmedizin. PMID 32869226.
Drake et al. (2018). Case report — pseudothrombophlebitis from ruptured Baker's cyst. J Med Case Rep. PMID 30249236.
Allam Y (2021). Popliteal ecchymosis sign in ruptured Baker's cyst. Cureus. PMID 33144131.
Yan B et al. (2018). Common peroneal nerve compression by extraneural popliteal cyst. Medicine (Baltimore). PMID 29668644.
Lin et al. (2021). Popliteal vein aneurysm masquerading as a Baker's cyst leading to PE. Vasc Endovascular Surg. PMID 34297976.
Hardin J (2016). Cystic adventitial disease of the popliteal artery in a young runner. J Am Board Fam Med. PMID 26933185.
Buisseret D et al. (1997). Adventitial cystic disease of the popliteal artery. Eur J Vasc Endovasc Surg. PMID 9357478.
Silveira LH et al. (1993). Candida arthritis with popliteal cyst infection. Rev Rhum Engl Ed. PMID 8484130.
NICE NG226 — Osteoarthritis in over 16s: diagnosis and management (2022). [cite-unverified] Operationalises Baker's cyst management inside the KOA pathway.
APTA — Treatment of Knee Osteoarthritis: Evidence-Based Clinical Practice Guideline, 3rd edition. [cite-unverified] Anchors KOA conservative pathway.